Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011)

A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India

NCT05329259 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population

NCT07071701 ·Status: COMPLETED

Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in PPSV23-vaccinated Healthy Adults ≥65 Years of Age (V114-007)

NCT02573181 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India.

NCT05875727 ·Status: COMPLETED ·Phase: PHASE3

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan

NCT04875533 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)

NCT02531373 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine

NCT05477693 ·Status: COMPLETED ·Phase: PHASE4

A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant

NCT07023081 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)

NCT00127153 ·Status: COMPLETED ·Phase: PHASE3

Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In India

NCT03777865 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

NCT05489328 ·Status: COMPLETED ·Phase: PHASE1

A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018)

NCT01734239 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Pneumococcal Vaccine in Healthy Infants

NCT00205803 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine

NCT02079207 ·Status: COMPLETED ·Phase: PHASE3

Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine

NCT06703203 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults

NCT00197821 ·Status: COMPLETED ·Phase: PHASE2

The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)

NCT01513551 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine

NCT04989465 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)

NCT05696080 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China

NCT01451086 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

NCT05092386 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)

NCT03547167 ·Status: COMPLETED ·Phase: PHASE3

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants

NCT04530838 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial to Evaluate the Safety and Immunogenicity of PPV23 Vaccine Revaccinated in 60-70 Years Old

NCT04700618 ·Status: COMPLETED ·Phase: PHASE4

Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

NCT07035054 ·Status: COMPLETED ·Phase: PHASE2